
Adventure Medical Kits
Littleton, New Hampshire, 1989 — first-aid kits laid out by injury rather than by item, built in the same house as SOL, Counter Assault and the consumer QuikClot line.

The kaolin hemostatic brand Teleflex bought with Z-Medica for $500 million in 2020 — and whose consumer-channel paperwork is the part nobody publishes.
QuikClot is a hemostatic dressing brand whose technology belongs to Teleflex, which completed its acquisition of Z-Medica on 28 December 2020 for $500 million in cash at closing plus up to $25 million in milestones. Teleflex describes the technology as a non-woven material impregnated with kaolin, and the professional site carries FDA clearance and authorization numbers for the devices it sells. The unresolved part is commercial rather than clinical — QuikClot also appears in the consumer outdoor channel under Adventure Ready Brands, and no public document found in this pass sets out the license or distribution agreement that puts it there.
QuikClot is one of the few brand names in bleeding control that a general reader recognizes, which makes it one of the few where getting the ownership chain right actually matters. The short version: the technology belongs to Teleflex.
Teleflex announced on 28 December 2020 that it had completed its acquisition of Z-Medica, LLC of Wallingford, Connecticut — the company that developed and manufactured QuikClot. The terms are in the release: an “upfront cash payment of $500 million at closing, and up to an additional $25 million upon the achievement of certain commercial milestones.” The same release states that the products “are manufactured in the United States.”
That is the medical-device side of the chain, and it is well documented.
QuikClot also appears in the outdoor consumer channel. The Adventure Ready Brands homepage lists QuikClot in its Adventure Health + Wellness platform next to Adventure Medical Kits, and QuikClot-branded product is sold in AMK packaging through outdoor retail.
No public document found in this pass sets out the arrangement. Whether it is a trademark license, a distribution agreement, a supply contract or some combination — and on what terms, for which SKUs, since when — is not published by Teleflex or by ARB. That gap is not a scandal. It is simply the commercial fact this page cannot state, so it doesn’t.
It matters for one practical reason: it means “QuikClot” on an outdoor shelf and “QuikClot” in a hospital purchasing system are the same brand reaching a buyer by two different routes, with different packaging and potentially different regulatory status per item.
In Teleflex’s own words on the QuikClot site, the technology is “a proprietary technology, which consists of a non-woven material impregnated with Kaolin,” and “Kaolin activates Factor XII, which in turn accelerates the clotting cascade leading to faster bleeding control.”
That is the manufacturer’s description of the mechanism. Everything about when, whether and how any such product is used belongs to the product’s own labeling and to training — this page does not paraphrase either, and neither should a retailer.
The site lists regulatory identifiers for the professional line: 510(k) K123387, 510(k) K072474, and De Novo DEN160012 for QuikClot Control+. Its footer states: “Federal (USA) law restricts these devices to sale or use by or on the order of a physician.”
FDA’s device recall database records recall Z-0211-2022: a Class 2 recall by Z-Medica, LLC covering QuikClot Combat Gauze, part number 200, for “Lack of Packaging seal integrity may result in a sterile barrier breach.” It was initiated 22 September 2021, covered 2,400 units in commerce, and FDA records it as terminated on 11 June 2024. A packaging-seal recall on a sterile product is a real event and a closed one; it is recorded here because a closed recall handled properly is a better signal than silence.
The consumer chain is opaque. A reader cannot find out from either company’s public pages who is responsible for what in the outdoor channel.
Two audiences, one name. The professional site is prescription-controlled by its own footer; consumer packages are sold over the counter. Nothing on the brand’s public pages maps which product belongs to which status.
Marketing sits downstream of labeling. Retail partners promote the brand with speed claims. The controlling document is always the product’s labeling, and the brand does not police what its channel says.
Origin is a 2020 statement. “Manufactured in the United States” was made about the acquired business at acquisition. It should be re-read off current labeling before anyone repeats it about a specific item.
Hemostatic dressings are a training-first category. The gear is downstream of a course, which is the same reason North American Rescue sells trainers alongside tourniquets. Kit builders will meet QuikClot inside packages from Adventure Medical Kits, My Medic and Chinook Medical — in each case the component’s own labeling, expiry date and status govern, not the bag it arrived in.
The nearest neighbors on the shelf — same categories first, same department after that.

Littleton, New Hampshire, 1989 — first-aid kits laid out by injury rather than by item, built in the same house as SOL, Counter Assault and the consumer QuikClot line.

Founded in Durango, Colorado in 1990, now in Tulsa — a licensed drug wholesaler that builds custom medical kits, majority-owned since 2015 by the employee who bought it.

North Salt Lake, Utah — the direct-to-consumer kit brand whose legal identity changed hands in January 2026, and whose own pages tell you which components came from where.

Greer, South Carolina, 1996 — the company behind the C-A-T tourniquet, and the loudest voice warning that counterfeit copies of it have reached responders and failed.